Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Omata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Omata, M.
Clinical Cancer Research Vol. 10, 2441-2446, April 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

UDP-Glucuronosyltransferase 1A7 Genetic Polymorphisms Are Associated with Hepatocellular Carcinoma in Japanese Patients with Hepatitis C Virus Infection

Yue Wang1, Naoya Kato1, Yujin Hoshida1, Motoyuki Otsuka1, Hiroyoshi Taniguchi1, Masaru Moriyama1, Shuichiro Shiina1, Takao Kawabe1, Yoichi M. Ito2 and Masao Omata1

1 Department of Gastroenterology, Graduate School of Medicine, and 2 Interfaculty Initiative in Information Studies, Graduate School of Interdisciplinary Information Studies, Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences and Nursing, University of Tokyo, Tokyo, Japan

Purpose: Genetic polymorphisms of UDP-glucuronosyltransferase 1A7 (UGT1A7), which detoxifies endogenous and environmental carcinogens, have been reported to be associated with hepatocellular carcinoma (HCC) in German populations. On the other hand, we reported that interleukin-1ß (IL-1ß) gene polymorphisms were associated with hepatitis C virus (HCV)-related HCC. In this study, we evaluated the association of both genes with the risk of HCC in Japanese HCV-infected patients.

Experimental Design: Genetic polymorphisms of UGT1A7 and IL-1ß were investigated in 280 Japanese patients (122 with HCC and 158 without HCC) with chronic HCV infections, by use of standard PCR-based genotyping techniques.

Results: We designated the UGT1A7*1 allele (a haplotype conferring higher activity) as H and the *2, *3, and *4 alleles (haplotypes conferring lower activity) as L. The proportions of UGT1A7 L/L and H/L alleles (genotypes) in patients with HCC (25% and 45%, respectively) were higher than those in patients without HCC (15% and 39%, respectively) with odds ratios of 2.73 (95% confidence interval, 1.40–5.35) and 1.80 (95% confidence interval, 1.05–3.09), respectively, compared with the UGT1A7 H/H alleles. Multivariate analyses revealed that UGT1A7 L/L and IL-1ß/–31T/T–511C/C genotypes, the presence of cirrhosis, age >60 years, male sex, and {alpha}-fetoprotein >20 µg/ml were associated with the presence of HCC (odds ratios, 2.33, 2.67, 4.20, 3.12, 3.09, and 2.90, respectively).

Conclusion: The UGT1A7 polymorphisms together with IL-1ß were associated with the presence of HCC in Japanese HCV-infected patients.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Budhu and X. W. Wang
The role of cytokines in hepatocellular carcinoma
J. Leukoc. Biol., December 1, 2006; 80(6): 1197 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Dharel, N. Kato, R. Muroyama, M. Moriyama, R.-X. Shao, T. Kawabe, and M. Omata
MDM2 Promoter SNP309 Is Associated with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C.
Clin. Cancer Res., August 15, 2006; 12(16): 4867 - 4871.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J.-Y. Han, H.-S. Lim, E. S. Shin, Y.-K. Yoo, Y. H. Park, J.-E. Lee, I.-J. Jang, D. Ho Lee, and J. Soo Lee
Comprehensive Analysis of UGT1A Polymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non-Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin
J. Clin. Oncol., May 20, 2006; 24(15): 2237 - 2244.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. O. Lankisch, A. Vogel, S. Eilermann, A. Fiebeler, B. Krone, A. Barut, M. P. Manns, and C. P. Strassburg
Identification and Characterization of a Functional TATA Box Polymorphism of the UDP Glucuronosyltransferase 1A7 Gene
Mol. Pharmacol., May 1, 2005; 67(5): 1732 - 1739.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Liu, F. Innocenti, M. J. Ratain, N. Kato, Y. Wang, and M. Omata
Linkage Disequilibrium across the UGT1A Locus Should Not Be Ignored in Association Studies of Cancer Susceptibility
Clin. Cancer Res., February 1, 2005; 11(3): 1348 - 1349.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.